Sign In
NewsRadar

Life Sciences Partners (LSP)

Life Sciences Partners ("LSP") is a leading European venture capital fund, providing private equity capital to early stage life sciences companies. Based in Amsterdam and Munich, LSP’s management has focused for over a decade on investing in human life sciences.


• Show past press releases
• Edit this company

Contact Information
Address:
 
 
Phone:
Fax:
Web:
Contact:
 
 
Johannes Vermeerplein 9
Amsterdam  1071 DV
Netherlands
+31 (0) 20 664 55 00
+31 (0) 20 676 88 10
http:///www.lsp.nl
Martijn Kleijwegt
+31 (0) 20 664 55 00

Company Facts
Type:
Capital managed:
Companies invested in:  
Investment managers:
Total staff size:
Number of offices:
Min. investment size:
Max. investment size:
Independent Investor (VC)
370 Mln Euro



3

Funding stages:Startups, Early Stages, Expansion
Geo. scope europe:North Europe, West Europe, Central Europe, South Europe
Investment distrib.:
Industry preferences:Other

Partners

  • Joachim Rothe
  • Jörg Neermann
  • Mark Wegter
  • Martijn Kleijwegt
  • René Kuijten
  • Tom Schwarz

    Portfolio

    Funds
    NameStatusClosingSize
    LSP BioventuresClosedJul 2006150 Mln Euro

    Remarks
    LSP invests in life sciences companies. Geographical Focus: Benelux and German-speaking countries


  • Data


    26,140
    Tech investments
    From our Online Data Service
    16,888
    VC-backed companies
    From our Radar


    Recent Deals


    DATEAMOUNTSECTOR
    Sep 13N/AEnergy related
    Sep 13€12.6MConsumer electronics
    Sep 12€39.0MBiopharmaceuticals
    Sep 12N/AKnowledge management
    Sep 12€2.3MInternet commerce
    Sep 12€2.1MInternet services
    Sep 12€4.0MMedical devices

    For information on Europe's most extensive database on technology funding click here!

    Events



    Press Releases


    May 28
    Identiq
    identiq raises $5m seed, launches privacy-first identity validation...

    Apr 29
    Nethone
    nethone raised over $1 million from innovation nest

    Oct 1
    The Link App
    the link app launches version 2.0

    Mar 29
    Addex Therapeutics
    addex sucessfully raises chf40 million in capital increase

    Jan 2
    Urban Jungle
    urban jungle raises 1m in seed funding to build tech-enabled home ...





    About usContact usLegal Information
    Copyright 1999-2019
    Emerging Technology Research Europe Inc. All rights reserved.